Biotech Pharmacon services gene therapy

The rise in clinical trials for prospective gene therapies has generated new business for Biotec Pharmacon ASA, a Norwegian company with a portfolio of research products derived from the natural environment.

Full text available to subscribers only. Click here for information on subscribing to MedNous.